TY - JOUR T1 - Late Breaking Abstract - PULMONARY REHABILITATION IN POST - COVID SUBJECTS WITH MODERATE LUNG RESTRICTION, A CASE SERIES JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.congress-2021.PA2003 VL - 58 IS - suppl 65 SP - PA2003 AU - Camilo Corbellini AU - Jorge Villafane AU - Elisa Gugliotta AU - Saverio Tavella AU - Stefano Zampese AU - Paolo Pessina AU - Riccardo Monti AU - Cosimina Carnuccio AU - Eleuterio A. Sanchez Romero AU - Roberto Meroni Y1 - 2021/09/05 UR - http://erj.ersjournals.com/content/58/suppl_65/PA2003.abstract N2 - Rehabilitation of Covid19 survivors is the next pandemic challenge. Recently ERS task force stated that data on safety and efficacy is still lacking. The goal of this case series is to present data related to pulmonary rehabilitation (PR) in post Covid19 subjects submitted to mechanical ventilation (MV), that developed pulmonary fibrosis, lung restrictive disorders, mild hypoxemia, loss of muscle mass, and exertion intolerance. From the November of 2020 up to April 2021 we screened 9 patients with history of prolonged MV, chest CT scan showing ground-glass opacities, lung restriction confirmed by body plethysmography. The subjects underwent inpatient PR according to the ERS/ATS statement at CASA DI CURA VILLA SERENA, Piossasco, Italy. All individuals followed an assessment protocol with a 6-minute walk test, lung function tests, and blood gas analysis. Rehabilitation protocol comprised aerobic and strength exercise training, respiratory physiotherapy, and pharmacologic treatment with cortisone and bronchodilators. Subjects were normoxemic and normocapnic in O2-therapy with mixed pulmonary disorder (moderate lung restriction, severe CO diffusion reduction). After PR patients improved functional status peripheric saturation during exertion and dyspnea (table 1). Data demonstrated that PR in post Covid19 patients with pulmonary fibrosis and lung restriction, improve exercise tolerance, oxygen saturation and dyspnea. FootnotesCite this article as: European Respiratory Journal 2021; 58: Suppl. 65, PA2003.This abstract was presented at the 2021 ERS International Congress, in session “Prediction of exacerbations in patients with COPD”.This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only). ER -